Dr. Reddy’s Enters US OTC Space With Bufferin, Other Ducere Brands
This article was originally published in The Tan Sheet & The Rose Sheet
Executive Summary
Indian generics giant Dr. Reddy’s has made its first foray into the $40bn branded US consumer health goods market, buying half a dozen over-the-counter (OTC) labels, including well-known names like painkiller Bufferin, from Ducere.